Jack A. Khattar - Feb 12, 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Feb 12, 2024
Transactions value $
$0
Form type
4
Date filed
2/22/2024, 05:28 PM
Previous filing
Dec 26, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Other +16.5K +1.87% 897K Feb 12, 2024 Direct F1
transaction SUPN Common Stock Other -16.5K -1.59% 1.02M Feb 12, 2024 By the KBT Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to reflect the fact that 16,500 shares were transferred from the KBT Trust to the Reporting Person on February 12, 2024 without consideration and are now owned directly.